Five-year Outcomes of Ranibizumab in Neovascular Age-related Macular Degeneration: Real Life Clinical Experience

PURPOSE: To evaluate the outcomes of 5-year ranibizumab treatment in neovascular age-related macular degeneration (nAMD) in a single center and real life clinical setting. METHODS: The records of nAMD patients who were treated with ranibizumab between January 2010 and June 2011 were retrospectively...

Descripción completa

Detalles Bibliográficos
Autores principales: Ozkaya, Abdullah, Alkin, Zeynep, Togac, Mesut, Ahmet, Sibel, Perente, Irfan, Taskapili, Muhittin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Korean Ophthalmological Society 2017
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636718/
https://www.ncbi.nlm.nih.gov/pubmed/28913999
http://dx.doi.org/10.3341/kjo.2016.0125

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5636718/
https://www.ncbi.nlm.nih.gov/pubmed/28913999
http://dx.doi.org/10.3341/kjo.2016.0125

Ejemplares similares